{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:03:16Z","timestamp":1795028596293,"version":"4.10.2"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:00:00Z","timestamp":1662163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:00:00Z","timestamp":1662163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the pathogen that causes COVID-19, produces polyproteins 1a and 1ab that contain, respectively, 11 or 16 non-structural proteins (nsp). Nsp5 is the main protease (M\n                    <jats:sup>pro<\/jats:sup>\n                    ) responsible for cleavage at eleven positions along these polyproteins, including at its own N- and C-terminal boundaries, representing essential processing events for viral assembly and maturation. Using C-terminally substituted M\n                    <jats:sup>pro<\/jats:sup>\n                    chimeras, we have determined X-ray crystallographic structures of M\n                    <jats:sup>pro<\/jats:sup>\n                    in complex with 10 of its 11 viral cleavage sites, bound at full occupancy intermolecularly in trans, within the active site of either the native enzyme and\/or a catalytic mutant (C145A). Capture of both acyl-enzyme intermediate and product-like complex forms of a P2(Leu) substrate in the native active site provides direct comparative characterization of these mechanistic steps as well as further informs the basis for enhanced product release of M\n                    <jats:sup>pro<\/jats:sup>\n                    \u2019s own unique C-terminal P2(Phe) cleavage site to prevent autoinhibition. We characterize the underlying noncovalent interactions governing binding and specificity for this diverse set of substrates, showing remarkable plasticity for subsites beyond the anchoring P1(Gln)-P2(Leu\/Val\/Phe), representing together a near complete analysis of a multiprocessing viral protease. Collectively, these crystallographic snapshots provide valuable mechanistic and structural insights for antiviral therapeutic development.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-32854-4","type":"journal-article","created":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T05:02:41Z","timestamp":1662181361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":106,"title":["X-ray crystallographic characterization of the SARS-CoV-2 main protease polyprotein cleavage sites essential for viral processing and maturation"],"prefix":"10.1038","volume":"13","author":[{"given":"Jaeyong","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calem","family":"Kenward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam J.","family":"Worrall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Vuckovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8299-1976","authenticated-orcid":false,"given":"Francesco","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7418-6563","authenticated-orcid":false,"given":"Anh-Tien","family":"Ton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1599-1439","authenticated-orcid":false,"given":"Artem","family":"Cherkasov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4058-9425","authenticated-orcid":false,"given":"Natalie C. J.","family":"Strynadka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7408-5487","authenticated-orcid":false,"given":"Mark","family":"Paetzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,3]]},"reference":[{"key":"32854_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu, F. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265\u2013269 (2020).","journal-title":"Nature"},{"key":"32854_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270\u2013273 (2020).","journal-title":"Nature"},{"key":"32854_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1099\/0022-1317-83-3-595","volume":"83","author":"A Hegyi","year":"2002","unstructured":"Hegyi, A. & Ziebuhr, J. Conservation of substrate specificities among coronavirus main proteases. J. Gen. Virol. 83, 595\u2013599 (2002).","journal-title":"J. Gen. Virol."},{"key":"32854_CR4","doi-asserted-by":"publisher","first-page":"127377","DOI":"10.1016\/j.bmcl.2020.127377","volume":"30","author":"S Ullrich","year":"2020","unstructured":"Ullrich, S. & Nitsche, C. The SARS-CoV-2 main protease as drug target. Bioorg. Med. Chem. Lett. 30, 127377 (2020).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"32854_CR5","doi-asserted-by":"publisher","first-page":"n2713","DOI":"10.1136\/bmj.n2713","volume":"375","author":"E Mahase","year":"2021","unstructured":"Mahase, E. Covid-19: Pfizer\u2019s paxlovid is 89% effective in patients at risk of serious illness, company reports. BMJ 375, n2713 (2021).","journal-title":"BMJ"},{"key":"32854_CR6","doi-asserted-by":"publisher","unstructured":"Jagdeo, J. M. et al. N-Terminomics TAILS identifies host cell substrates of poliovirus and coxsackievirus B3 3C proteinases that modulate virus infection. J. Virol. https:\/\/doi.org\/10.1128\/JVI.02211-17 (2018).","DOI":"10.1128\/JVI.02211-17"},{"key":"32854_CR7","doi-asserted-by":"publisher","first-page":"109892","DOI":"10.1016\/j.celrep.2021.109892","volume":"37","author":"I Pablos","year":"2021","unstructured":"Pablos, I. et al. Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CL. Cell Rep. 37, 109892 (2021).","journal-title":"Cell Rep."},{"key":"32854_CR8","doi-asserted-by":"publisher","first-page":"e2000246","DOI":"10.1002\/pmic.202000246","volume":"21","author":"T Koudelka","year":"2021","unstructured":"Koudelka, T. et al. N-Terminomics for the identification of in vitro substrates and cleavage site specificity of the SARS-CoV-2 main protease. Proteomics 21, e2000246 (2021).","journal-title":"Proteomics"},{"key":"32854_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Z Jin","year":"2020","unstructured":"Jin, Z. et al. Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors. Nature 582, 289\u2013293 (2020).","journal-title":"Nature"},{"key":"32854_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.abb3405","volume":"368","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors. Science 368, 409\u2013412 (2020).","journal-title":"Science"},{"key":"32854_CR11","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.bbrc.2004.04.098","volume":"318","author":"CJ Kuo","year":"2004","unstructured":"Kuo, C. J., Chi, Y. H., Hsu, J. T. & Liang, P. H. Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate. Biochem. Biophys. Res. Commun. 318, 862\u2013867 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"32854_CR12","doi-asserted-by":"publisher","first-page":"22741","DOI":"10.1074\/jbc.M502556200","volume":"280","author":"WC Hsu","year":"2005","unstructured":"Hsu, W. C. et al. Critical assessment of important regions in the subunit association and catalytic action of the severe acute respiratory syndrome coronavirus main protease. J. Biol. Chem. 280, 22741\u201322748 (2005).","journal-title":"J. Biol. Chem."},{"key":"32854_CR13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/jb\/mvq071","volume":"148","author":"MY Tsai","year":"2010","unstructured":"Tsai, M. Y. et al. Essential covalent linkage between the chymotrypsin-like domain and the extra domain of the SARS-CoV main protease. J. Biochem. 148, 349\u2013358 (2010).","journal-title":"J. Biochem."},{"key":"32854_CR14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s13238-011-1034-1","volume":"2","author":"B Xia","year":"2011","unstructured":"Xia, B. & Kang, X. Activation and maturation of SARS-CoV main protease. Protein Cell 2, 282\u2013290 (2011).","journal-title":"Protein Cell"},{"key":"32854_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16954-7","volume":"11","author":"DW Kneller","year":"2020","unstructured":"Kneller, D. W. et al. Structural plasticity of SARS-CoV-2 3CL M(pro) active site cavity revealed by room temperature X-ray crystallography. Nat. Commun. 11, 3202 (2020).","journal-title":"Nat. Commun."},{"key":"32854_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/BF02174046","volume":"6","author":"AE Gorbalenya","year":"1996","unstructured":"Gorbalenya, A. E. & Snijder, E. J. Viral cysteine proteinases. Perspect. Drug Discov. Des. 6, 64\u201386 (1996).","journal-title":"Perspect. Drug Discov. Des."},{"key":"32854_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18709-w","volume":"11","author":"A Douangamath","year":"2020","unstructured":"Douangamath, A. et al. Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease. Nat. Commun. 11, 5047 (2020).","journal-title":"Nat. Commun."},{"key":"32854_CR18","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1126\/science.abl4784","volume":"374","author":"DR Owen","year":"2021","unstructured":"Owen, D. R. et al. An oral SARS-CoV-2 M. Science 374, 1586\u20131593 (2021).","journal-title":"Science"},{"key":"32854_CR19","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1021\/jacs.1c08402","volume":"144","author":"A Luttens","year":"2022","unstructured":"Luttens, A. et al. Ultralarge virtual screening identifies SARS-CoV-2 main protease inhibitors with broad-spectrum activity against coronaviruses. J. Am. Chem. Soc. 144, 2905\u20132920 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"32854_CR20","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1107\/S2052252521010113","volume":"8","author":"DW Kneller","year":"2021","unstructured":"Kneller, D. W., Zhang, Q., Coates, L., Louis, J. M. & Kovalevsky, A. Michaelis-like complex of SARS-CoV-2 main protease visualized by room-temperature X-ray crystallography. IUCrJ 8, 973\u2013979 (2021).","journal-title":"IUCrJ"},{"key":"32854_CR21","doi-asserted-by":"publisher","first-page":"e2117142119","DOI":"10.1073\/pnas.2117142119","volume":"119","author":"Y Zhao","year":"2022","unstructured":"Zhao, Y. et al. Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2. Proc. Natl Acad. Sci. USA 119, e2117142119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"32854_CR22","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1021\/acsinfecdis.1c00237","volume":"7","author":"EA MacDonald","year":"2021","unstructured":"MacDonald, E. A. et al. Recognition of divergent viral substrates by the SARS-CoV-2 main protease. ACS Infect. Dis. 7, 2591\u20132595 (2021).","journal-title":"ACS Infect. Dis."},{"key":"32854_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31210-w","volume":"13","author":"AM Shaqra","year":"2022","unstructured":"Shaqra, A. M. et al. Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance. Nat. Commun. 13, 3556 (2022).","journal-title":"Nat. Commun."},{"key":"32854_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19662-4","volume":"11","author":"J Lee","year":"2020","unstructured":"Lee, J. et al. Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site. Nat. Commun. 11, 5877 (2020).","journal-title":"Nat. Commun."},{"key":"32854_CR25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41589-020-00689-z","volume":"17","author":"W Rut","year":"2021","unstructured":"Rut, W. et al. SARS-CoV-2 M. Nat. Chem. Biol. 17, 222\u2013228 (2021).","journal-title":"Nat. Chem. Biol."},{"key":"32854_CR26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s13238-010-0044-8","volume":"1","author":"S Zhang","year":"2010","unstructured":"Zhang, S. et al. Three-dimensional domain swapping as a mechanism to lock the active conformation in a super-active octamer of SARS-CoV main protease. Protein Cell 1, 371\u2013383 (2010).","journal-title":"Protein Cell"},{"key":"32854_CR27","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","volume":"372","author":"E Krissinel","year":"2007","unstructured":"Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774\u2013797 (2007).","journal-title":"J. Mol. Biol."},{"key":"32854_CR28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"32854_CR29","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1042\/BCJ20200029","volume":"477","author":"B Krichel","year":"2020","unstructured":"Krichel, B., Falke, S., Hilgenfeld, R., Redecke, L. & Uetrecht, C. Processing of the SARS-CoV pp1a\/ab nsp7-10 region. Biochem. J. 477, 1009\u20131019 (2020).","journal-title":"Biochem. J."},{"key":"32854_CR30","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1021\/cr040669e","volume":"105","author":"JD Tyndall","year":"2005","unstructured":"Tyndall, J. D., Nall, T. & Fairlie, D. P. Proteases universally recognize beta strands in their active sites. Chem. Rev. 105, 973\u2013999 (2005).","journal-title":"Chem. Rev."},{"key":"32854_CR31","doi-asserted-by":"publisher","first-page":"17365","DOI":"10.1074\/jbc.AC120.016154","volume":"295","author":"DW Kneller","year":"2020","unstructured":"Kneller, D. W. et al. Unusual zwitterionic catalytic site of SARS-CoV-2 main protease revealed by neutron crystallography. J. Biol. Chem. 295, 17365\u201317373 (2020).","journal-title":"J. Biol. Chem."},{"key":"32854_CR32","doi-asserted-by":"publisher","first-page":"17366","DOI":"10.1021\/acs.jmedchem.1c01475","volume":"64","author":"DW Kneller","year":"2021","unstructured":"Kneller, D. W. et al. Structural, electronic, and electrostatic determinants for inhibitor binding to subsites S1 and S2 in SARS-CoV-2 main protease. J. Med. Chem. 64, 17366\u201317383 (2021).","journal-title":"J. Med. Chem."},{"key":"32854_CR33","doi-asserted-by":"publisher","first-page":"12725","DOI":"10.1021\/acs.jmedchem.0c01063","volume":"63","author":"RL Hoffman","year":"2020","unstructured":"Hoffman, R. L. et al. Discovery of ketone-based covalent inhibitors of coronavirus 3CL proteases for the potential therapeutic treatment of COVID-19. J. Med. Chem. 63, 12725\u201312747 (2020).","journal-title":"J. Med. Chem."},{"key":"32854_CR34","doi-asserted-by":"publisher","first-page":"e324","DOI":"10.1371\/journal.pbio.0030324","volume":"3","author":"H Yang","year":"2005","unstructured":"Yang, H. et al. Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biol. 3, e324 (2005).","journal-title":"PLoS Biol."},{"key":"32854_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18096-2","volume":"11","author":"W Vuong","year":"2020","unstructured":"Vuong, W. et al. Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication. Nat. Commun. 11, 4282 (2020).","journal-title":"Nat. Commun."},{"key":"32854_CR36","doi-asserted-by":"publisher","unstructured":"Ma, C. et al. Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease. Cell Res. https:\/\/doi.org\/10.1038\/s41422-020-0356-z (2020).","DOI":"10.1038\/s41422-020-0356-z"},{"key":"32854_CR37","doi-asserted-by":"publisher","first-page":"e0245962","DOI":"10.1371\/journal.pone.0245962","volume":"16","author":"JD Baker","year":"2021","unstructured":"Baker, J. D., Uhrich, R. L., Kraemer, G. C., Love, J. E. & Kraemer, B. C. A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease. PLoS One 16, e0245962 (2021).","journal-title":"PLoS One"},{"key":"32854_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18233-x","volume":"11","author":"L Fu","year":"2020","unstructured":"Fu, L. et al. Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease. Nat. Commun. 11, 4417 (2020).","journal-title":"Nat. Commun."},{"key":"32854_CR39","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.str.2020.10.007","volume":"28","author":"DW Kneller","year":"2020","unstructured":"Kneller, D. W. et al. Malleability of the SARS-CoV-2 3CL Mpro active-site cavity facilitates binding of clinical antivirals. Structure 28, 1313\u20131320.e1313 (2020).","journal-title":"Structure"},{"key":"32854_CR40","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ejmech.2013.07.037","volume":"68","author":"P Thanigaimalai","year":"2013","unstructured":"Thanigaimalai, P. et al. Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies. Eur. J. Med. Chem. 68, 372\u2013384 (2013).","journal-title":"Eur. J. Med. Chem."},{"key":"32854_CR41","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.bmc.2012.11.017","volume":"21","author":"S Konno","year":"2013","unstructured":"Konno, S. et al. Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety. Bioorg. Med. Chem. 21, 412\u2013424 (2013).","journal-title":"Bioorg. Med. Chem."},{"key":"32854_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2012.10.053","volume":"59","author":"CP Chuck","year":"2013","unstructured":"Chuck, C. P. et al. Design, synthesis and crystallographic analysis of nitrile-based broad-spectrum peptidomimetic inhibitors for coronavirus 3C-like proteases. Eur. J. Med. Chem. 59, 1\u20136 (2013).","journal-title":"Eur. J. Med. Chem."},{"key":"32854_CR43","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41557-020-0496-2","volume":"12","author":"J Chodera","year":"2020","unstructured":"Chodera, J., Lee, A. A., London, N. & von Delft, F. Crowdsourcing drug discovery for pandemics. Nat. Chem. 12, 581 (2020).","journal-title":"Nat. Chem."},{"key":"32854_CR44","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1021\/acscentsci.1c00039","volume":"7","author":"CH Zhang","year":"2021","unstructured":"Zhang, C. H. et al. Potent noncovalent inhibitors of the main protease of SARS-CoV-2 from molecular sculpting of the drug perampanel guided by free energy perturbation calculations. ACS Cent. Sci. 7, 467\u2013475 (2021).","journal-title":"ACS Cent. Sci."},{"key":"32854_CR45","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.str.2021.06.002","volume":"29","author":"MG Deshmukh","year":"2021","unstructured":"Deshmukh, M. G. et al. Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease. Structure 29, 823\u2013833.e825 (2021).","journal-title":"Structure"},{"key":"32854_CR46","doi-asserted-by":"publisher","first-page":"128629","DOI":"10.1016\/j.bmcl.2022.128629","volume":"62","author":"S Ullrich","year":"2022","unstructured":"Ullrich, S., Ekanayake, K. B., Otting, G. & Nitsche, C. Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir. Bioorg. Med. Chem. Lett. 62, 128629 (2022).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"32854_CR47","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/iub.2465","volume":"73","author":"N Krishnamoorthy","year":"2021","unstructured":"Krishnamoorthy, N. & Fakhro, K. Identification of mutation resistance coldspots for targeting the SARS-CoV2 main protease. IUBMB Life 73, 670\u2013675 (2021).","journal-title":"IUBMB Life"},{"key":"32854_CR48","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1107\/S0021889809045701","volume":"43","author":"G Winter","year":"2010","unstructured":"Winter, G. xia2: An expert system for macromolecular crystallography data reduction. J. Appl. Crystallogr. 43, 186\u2013190 (2010).","journal-title":"J. Appl. Crystallogr."},{"key":"32854_CR49","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. Xds. Acta Crystallogr. D Biol. Crystallogr. 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"32854_CR50","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1107\/S0907444913000061","volume":"69","author":"PR Evans","year":"2013","unstructured":"Evans, P. R. & Murshudov, G. N. How good are my data and what is the resolution? Acta Crystallogr. D Biol. Crystallogr. 69, 1204\u20131214 (2013).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"32854_CR51","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","volume":"67","author":"MD Winn","year":"2011","unstructured":"Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67, 235\u2013242 (2011).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"32854_CR52","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"32854_CR53","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"32854_CR54","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1107\/S0907444902016657","volume":"58","author":"PD Adams","year":"2002","unstructured":"Adams, P. D. et al. PHENIX: Building new software for automated crystallographic structure determination. Acta Crystallogr. D. Biol. Crystallogr. 58, 1948\u20131954 (2002).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"32854_CR55","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1107\/S1399004714024572","volume":"70","author":"M Kowiel","year":"2014","unstructured":"Kowiel, M., Jaskolski, M. & Dauter, Z. ACHESYM: An algorithm and server for standardized placement of macromolecular models in the unit cell. Acta Crystallogr. D Biol. Crystallogr. 70, 3290\u20133298 (2014).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"32854_CR56","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: All-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"32854_CR57","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1107\/S2059798316018210","volume":"73","author":"D Liebschner","year":"2017","unstructured":"Liebschner, D. et al. Polder maps: Improving OMIT maps by excluding bulk solvent. Acta Crystallogr. D Struct. Biol. 73, 148\u2013157 (2017).","journal-title":"Acta Crystallogr. D Struct. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32854-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32854-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32854-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T06:03:04Z","timestamp":1662184984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32854-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,3]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["32854"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-32854-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,3]]},"assertion":[{"value":"14 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5196"}}